Smoking history not assessed in cancer trials, study finds

June 14, 2012, Yale University

Cancer trials typically do not assess smoking history of participants even though studies have shown tobacco use has adverse effects on cancer treatments, researchers at Roswell Park Cancer Institute and Yale Cancer Center report in a study published in the Journal of Cancer Oncology.

The study — led by Dr. Graham Warren at Roswell Park and conducted by Yale psychiatry postdoctoral researcher Erica N. Peters — looked at 155 National Cancer Institute-sponsored trials, and showed that only 29% assessed tobacco use.

“It is shocking that most of these trials don’t assess ,” said Dr. Benjamin Toll, Peters’ mentor in psychiatry.

Explore further: Study recommends national standards for tobacco use treatment

More information: jco.ascopubs.org/cgi/doi/10.1200/JCO.2011.40.8815

Related Stories

Study recommends national standards for tobacco use treatment

April 17, 2012
A cancer diagnosis doesn’t automatically get people to stop smoking, but continuing to smoke shortens patients’ survival, increases their risk for a second tumor, and is associated with worse outcomes after cancer ...

Nanoparticles cut off 'addicted' tumors from source of their survival

May 28, 2012
(Medical Xpress) -- Yale biologists and engineers have designed drug-loaded nanoparticles that target the soft underbelly of many types of cancer — a tiny gene product that tumors depend upon to replicate and survive.

Many people continue to smoke after being diagnosed with cancer

January 23, 2012
A new analysis has found that a substantial number of lung and colorectal cancer patients continue to smoke after being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, ...

Barrett's patients who smoke twice as likely to develop oesophageal cancer

January 30, 2012
Smoking doubles the risk of developing oesophageal cancer in people with Barrett's Oesophagus, according to scientists at Queen's University Belfast and the Northern Ireland Cancer Registry.

Cuba releases world's first lung cancer vaccine

September 8, 2011
(Medical Xpress) -- As the most common and deadliest form of cancer, lung cancer kills 1.4 million people per year worldwide, according to the World Health Organization. While current treatments may improve the survival rate ...

Recommended for you

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Scientists block the siren call of two aggressive cancers

January 23, 2018
Aggressive cancers like glioblastoma and metastatic breast cancer have in common a siren call that beckons the bone marrow to send along whatever the tumors need to survive and thrive.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.